Chester County News and Community Website
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) has released its financial results for the third quarter of 2024, highlighting both solid revenue growth and strategic milestones. The company reported …
Bentley Systems Reports Strong Third Quarter 2024 Financial Performance and Strategic Advances Read More
WAYNE, PA — Trinseo (NYSE: TSE) announced its financial results for the third quarter of 2024, reporting net sales of $868 million, a slight decline of 1% compared to the …
Trinseo Reports Mixed Results for Third Quarter 2024 Amid Strategic Restructuring Read More
PLYMOUTH MEETING, PA — AdaptHealth Corp. (NASDAQ: AHCO) has released its financial results for the third quarter ending September 30, 2024, showing a slight increase in net revenue and a …
AdaptHealth Corp. Reports Improved Third-Quarter Earnings and Updates Financial Outlook Read More
BRYN MAWR, PA — Essential Utilities Inc. (NYSE: WTRG) has released its financial results for the third quarter of 2024, reporting a net income of $69.4 million, or $0.25 per …
Essential Utilities Reports Solid Third-Quarter Earnings and Ambitious Future Plans Read More
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has announced its financial results for the third quarter of 2024, alongside significant progress in its clinical and preclinical programs. The company …
Carisma Therapeutics Reports Q3 2024 Results, Advances Clinical Programs Read More
NEWTOWN, PA — EPAM Systems, Inc. (NYSE: EPAM) has released its financial results for the third quarter ending September 30, 2024, showcasing steady growth and strategic advancements. The company reported …
EPAM Systems Reports Strong Q3 2024 Financial Performance, Expands Through Strategic Initiatives Read More
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) announced its financial results for the third quarter ending September 30, 2024, following the acquisition of assets from Endo International plc earlier this …
Endo, Inc. Reports Third-Quarter 2024 Financial Results Amid Strategic Developments Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reported its financial results for the third quarter of 2024, highlighting significant advancements in its gene therapy programs and financial strategies. The …
Ocugen Advances Gene Therapy and Financial Strategies in Q3 2024 Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced impressive financial results for the third quarter of 2024, achieving a record revenue of $19.0 million. This marks a robust …
TELA Bio Reports Strong Revenue Growth in Q3 2024 Read More
DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) released its third-quarter financial results for 2024, reporting key advancements in its clinical-stage therapeutic candidates. The company is making significant strides in …
Aprea Therapeutics Reports Q3 Financials and Advances in Clinical Trials Read More